http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#Head
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#assertion
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#provenance
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#pubinfo
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#assertion
http://purl.obolibrary.org/obo/MONDO_0005452
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/MONDO_0005452
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://go.drugbank.com/drugs/DB01255
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
http://www.w3.org/2000/01/rdf-schema#label
Of relevance, lisdexamfetamine dimesylate, a psy- chostimulant approved for the treatment of ADHD, has been recently assessed and approved for the treat- ment of moderate to severe binge eating disorder in adults.5,6 In a phase 2 efficacy and safety trial, pa- tients with binge eating disorder who were prescribed doses of 50 and 70 mg/day doses of lisdexamfetamine demonstrated reduced binge eating days per week, greater binge eating cessation rates, and greater rates of clinical global improvement at 11 weeks compared with the placebo control group
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
https://w3id.org/biolink/vocab/has_population_context
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#cohort
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
https://w3id.org/biolink/vocab/publications
https://pubmed.ncbi.nlm.nih.gov/28125174/
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/OffLabelIndication
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#cohort
http://www.w3.org/2000/01/rdf-schema#label
Adults
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#cohort
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Cohort
https://go.drugbank.com/drugs/DB01255
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#provenance
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#pubinfo
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#sig
http://purl.org/nanopub/x/hasSignature
PCDPwKiHmsH80UaIs0rt9FS3fcNixmWn4eRPirgozVk8qKEPH2rM6RjOErxw1MP+93czBmLUs92nPOhwPM428RQjRO+Z6b3qYvi7ZV+J2BWtXOcqT76T0GLpNWQDiM6iEfOHh4SUAkg8VqFCerh+2uiXK8xnHHS3JmY/JkjXzUQ=
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
http://purl.org/dc/terms/created
2021-05-31T10:52:02.178+02:00
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs